Reproductive toxicity study with a novel deoxyguanosine analogue (Metacavir) in pregnant SD rats

[1]  C. Gnoula,et al.  PMTCT of HIV-1 in Burkina Faso: evaluation of residual vertical transmission by PCR, molecular characterization of subtypes and determination of antiretroviral drugs resistance , 2014, BMC Infectious Diseases.

[2]  Peninnah Oberdorfer,et al.  Hematological alterations and thymic function in newborns of HIV-infected mothers receiving antiretroviral drugs , 2013, Indian Pediatrics.

[3]  Li Tang,et al.  Six-month repeated dose toxicity of orally administered metacavir in rhesus monkeys. , 2011, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[4]  Luyong Zhang,et al.  Evaluation of Mitochondrial Toxicity in Marmota himalayana Treated with Metacavir, a Novel 2′,3′-Dideoxyguanosine Prodrug for Treatment of Hepatitis B Virus , 2011, Antimicrobial Agents and Chemotherapy.

[5]  Zhengli Chen,et al.  In vivo assessment of mitochondrial toxicity of metacavir in Rhesus monkeys after three months of intravenous administration , 2009, Acta Pharmacologica Sinica.

[6]  Tao Wang,et al.  A sensitive and specific liquid chromatography-mass spectrometry method for determination of metacavir in rat plasma. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  Jeng-Hsiu Hung,et al.  Lamivudine therapy in the treatment of chronic hepatitis B with acute exacerbation during pregnancy. , 2008, Journal of the Chinese Medical Association : JCMA.

[8]  A. Cheng,et al.  Antiviral effects of PNA in duck hepatitis B virus infection model , 2007, Acta Pharmacologica Sinica.

[9]  L. Telegdy.  [Treatment of hepatitis B]. , 2004, Orvosi Hetilap.

[10]  R. Malekzadeh,et al.  Hepatitis B. , 2004, New England Journal of Medicine.

[11]  D. H. Watts,et al.  Management of human immunodeficiency virus infection in pregnancy. , 2002, The New England journal of medicine.

[12]  Cott,et al.  ANTIRETROVIRAL THERAPY DURING PREGNANCY AND THE RISK OF AN ADVERSE OUTCOME , 2002 .

[13]  B. Hirschel,et al.  Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects , 1998, AIDS.

[14]  James G. Wilson.  Teratology: Principles and Techniques , 1965 .

[15]  J. Wilson.  Methods for administering agents and detecting malformations in experimental animals , 1965 .

[16]  Staples Re,et al.  REFINEMENTS IN RAPID CLEARING TECHNIC IN THE KOH-ALIZARIN RED S METHOD FOR FETAL BONE. , 1964 .